Connect with us

NEWS

NAFDAC licenses ABUAD to produce COVID-19 herbal drug

Published

on

National Agency for Food and Drug Administration and Control (NAFDAC) has given approval to Afe Babalola University Ado-Ekiti (ABUAD) to commence production of ABUAD Herbal Virucidine Liquid with effect from December 16, 2021.

  The approval was conveyed in a letter dated December 17, 2021, and signed by Director-General of NAFDAC, Prof. Mojisola C. Adeyeye.

According to a statement by ABUAD Director of Corporate Affairs, Tunde Olofintila, with this achievement ABUAD has joined researchers in some foreign universities, which have been making efforts to produce anti-viral medications for the treatment of COVID-19.

  In his comment on the development, Founder & Chancellor of the university, Afe Babalola, recalled that the university was founded on three pillars of quality and functional education, research and community service in order to reform education and revive research in Nigerian Universities.

  It will be recalled that ABUAD Herbal Virucidine Liquid is an immune booster and antioxidant for coronavirus and other viral infections, which can also be used as an anti-inflammatory agent. It is a product, which has been conscientiously produced and packaged in 100-ml bottles.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published.

Advertisement
Advertisement
Advertisement

Top Posts

Advertisement

Trending